These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19271098)

  • 21. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis.
    Stevenson M; Gomersall T; Lloyd Jones M; Rawdin A; Hernández M; Dias S; Wilson D; Rees A
    Health Technol Assess; 2014 Mar; 18(17):1-290. PubMed ID: 24650687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.
    Kreck S; Klaus J; Leidl R; von Tirpitz C; Konnopka A; Matschinger H; König HH
    Pharmacoeconomics; 2008; 26(4):311-28. PubMed ID: 18370566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture.
    Majumdar SR; Lier DA; Rowe BH; Russell AS; McAlister FA; Maksymowych WP; Hanley DA; Morrish DW; Johnson JA
    Osteoporos Int; 2011 Jun; 22(6):1799-808. PubMed ID: 20878389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effective osteoporosis treatment thresholds: the United States perspective.
    Tosteson AN; Melton LJ; Dawson-Hughes B; Baim S; Favus MJ; Khosla S; Lindsay RL;
    Osteoporos Int; 2008 Apr; 19(4):437-47. PubMed ID: 18292976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of hip and vertebral fractures on quality-adjusted life years.
    Tosteson AN; Gabriel SE; Grove MR; Moncur MM; Kneeland TS; Melton LJ
    Osteoporos Int; 2001 Dec; 12(12):1042-9. PubMed ID: 11846331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Si L; Winzenberg TM; Jiang Q; Palmer AJ
    Osteoporos Int; 2015 May; 26(5):1477-89. PubMed ID: 25567776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.
    Jansen JP; Gaugris S; Bergman G; Sen SS
    Curr Med Res Opin; 2008 Mar; 24(3):671-84. PubMed ID: 18221588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valuing the health states associated with Chlamydia trachomatis infections and their sequelae: a systematic review of economic evaluations and primary studies.
    Jackson LJ; Auguste P; Low N; Roberts TE
    Value Health; 2014; 17(1):116-30. PubMed ID: 24438725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review of health state utility values for acute myeloid leukemia.
    Forsythe A; Brandt PS; Dolph M; Patel S; Rabe APJ; Tremblay G
    Clinicoecon Outcomes Res; 2018; 10():83-92. PubMed ID: 29416365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups.
    Burch J; Rice S; Yang H; Neilson A; Stirk L; Francis R; Holloway P; Selby P; Craig D
    Health Technol Assess; 2014 Feb; 18(11):1-180. PubMed ID: 24534414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system.
    Solomon DH; Patrick AR; Schousboe J; Losina E
    J Bone Miner Res; 2014 Jul; 29(7):1667-74. PubMed ID: 24443384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review of health state utility values for economic evaluation of colorectal cancer.
    Jeong K; Cairns J
    Health Econ Rev; 2016 Dec; 6(1):36. PubMed ID: 27541298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
    Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review of health state utility values and psychometric performance of generic preference-based instruments for children and adolescents with mental health problems.
    Thai TTH; Engel L; Perez JK; Tan EJ; Eades S; Sanci L; Mihalopoulos C
    Qual Life Res; 2023 Nov; 32(11):3005-3026. PubMed ID: 37237136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective.
    Borgström F; Carlsson A; Sintonen H; Boonen S; Haentjens P; Burge R; Johnell O; Jönsson B; Kanis JA
    Osteoporos Int; 2006; 17(7):996-1007. PubMed ID: 16570118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring health state utility values of parents of children with a serious illness.
    Majmudar IK; Engel L; Muscara F; Stevenson C; McCarthy M; Anderson V; Mihalopoulos C
    Qual Life Res; 2020 Jul; 29(7):1947-1959. PubMed ID: 32335816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.